In this study, we have successfully tackled this drawback by endowing iNKT cells with a high affinity BCMA-CAR and with an affinity-optimized CD38-CAR, which selectively recognizes the high levels of CD38 antigen expressed on MM cells due to its attenuated CD38 affinity [43]. The gene discussed is CD38; the disease is Miyoshi myopathy.